Brickell Biotech Inc (NASDAQ:BBI)
North American company
Share Price Chart
- Chart currently unavailable -
Market Info - BBI
- Market Open Price0.00
- Previous Close0.00
- Volume-
- 52w Low/High-
- Last Trade Price0.00
- Bid/Ask Price0.00
Company Info - BBI
- Market Cap$58.870m
- SymbolNASDAQ:BBI
- IndustryHealthcare
- SectorBiotechnology
- Currency
- ISINUS10802T1051
Company Profile
Brickell Biotech Inc is a United States-based clinical-stage pharmaceutical company focused on developing therapeutics for the treatment of skin diseases. Its pipeline consists of therapeutics for Hyperhidrosis, Cutaneous T-cell lymphoma, Psoriasis, and Other prevalent severe skin diseases. The company's pipeline products include Sofpironium Bromide, BBI-3000 and BBI-6000 among others.Vical Inc is engaged in research and development of biopharmaceutical products based on its patented DNA delivery technologies for the prevention and treatment of serious or life-threatening diseases.
Latest BBI news
Currently there for this company. Visit our news hub for other news .